Private-Pay Home Health Provider Spring Hills Taking ‘All-in-One’ Approach to Post-Acute Care

Spring Hills wants to be able to do everything that other home-based care agencies do, while also doing everything that they don’t do. Based in Woodbury, New Jersey, the company takes a bit of a different approach to home care — it actually considers itself a private-pay home health provider. Its ultimate goal is to …

Private-Pay Home Health Provider Spring Hills Taking ‘All-in-One’ Approach to Post-Acute Care Read More »

Future Leader: Chelsey Ammons, Care Advantage’s Vice President of Nursing

The Future Leaders Awards program is brought to you in partnership with PointClickCare. The program is designed to recognize up-and-coming industry members who are shaping the next decade of senior housing, skilled nursing, home health and hospice care. To see this year’s future leaders, visit https://futureleaders.agingmedia.com/. Chelsey Ammons, vice president of nursing at Richmond, Virginia-based …

Future Leader: Chelsey Ammons, Care Advantage’s Vice President of Nursing Read More »

Hive is a new & potentially devastating type of ransomware. Here’s what you need to know.

This new type of ransomware — which was linked to a cyberattack against an Ohio-based health system in August — employs a multi-pronged approach, focusing not only on encrypting sensitive data but also on terminating backup processes to make it harder for organizations to recover from the attack.

Leader of California’s Muscular Obamacare Exchange to Step Down

Peter Lee, who has steered California’s Affordable Care Act marketplace since late 2011 and helped mold it into a model of what the federal health care law could achieve, announced Thursday he will leave his post in March. As executive director of Covered California, Lee has worked closely with the administrations of Democratic presidents Barack …

Leader of California’s Muscular Obamacare Exchange to Step Down Read More »

Marburg virus outbreak comes to an end in Guinea

The outbreak of the Marburg virus has come to an end in Guinea, the World Health Organization’s (WHO) African Region announced on Thursday. There have been no new cases in the past 42 days with only one case ever recorded from the…

Italy requires all workers to present COVID-19 health passes

Italy is requiring all its public and private section workers to present COVID-19 health passes in order to keep working and getting paid. The government voted on Thursday to require by Oct. 15 that all workers have health passes that…

DOJ moves to block Purdue Pharma deal shielding Sacklers

The Department of Justice (DOJ) moved on Wednesday to block Purdue Pharma’s controversial bankruptcy deal that shields members of the Sackler family from being sued in future opioid-related lawsuits. U.S Trustee for the DOJ William Harrington…

KHN’s ‘What the Health?’: Much Ado About Drug Prices

Can’t see the audio player? Click here to listen on SoundCloud. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts. Congressional Democrats are finding it harder to actually write legislation to lower drug prices than it is to make promises about it. But the drug price provisions of the $3.5 trillion social-spending bill …

KHN’s ‘What the Health?’: Much Ado About Drug Prices Read More »

Syntegon AIM 5

The Syntegon AIM 5 utilizes an AI vision system for the inspection of syringe flanges, stoppers, and cylinders.

Telehealth: Short-Term Fad or Key to Improving Access to Affordable Healthcare?

Stephanie Jamison, Director of Regulatory Affairs, Greenway Health While telehealth offerings have always held great promise, prior to 2020, their success was sometimes hindered by provider hesitation to adopt the technology, consumer reluctance to using virtual care, and a reimbursement methodology that did not value the investments required by providers or the positive impact on …

Telehealth: Short-Term Fad or Key to Improving Access to Affordable Healthcare? Read More »

Ipca Laboratories -Walk-In Interviews for Production/ Quality Control On 19th September 2021

Ipca Laboratories -Walk-In Interviews for Production/ Quality Control On 19th September 2021 Job Description Department: Production/ Quality Control Positions: Jr. Officer/ Sr. Officer/ Officer Educational Qualification: B.A, B.Sc, B.Pharm Experience: 1-6 years Location: Athal, Silvassa, D&NH&DD Time and Venue Details: Walk-In Interview On 19th September 2021 From 09:00 AM to 16:30 , Venue: Hotel Sovereign & Hotel Gurukripa, Sea Face Road, Daman …

Ipca Laboratories -Walk-In Interviews for Production/ Quality Control On 19th September 2021 Read More »

3,000 health workers suspended in France over vaccine mandate

Approximately 3,000 workers from hospitals, care homes and health centers in France have been suspended for not complying with the country’s requirement that they receive the COVID-19 vaccine.French President Emmanuel Macron announced…

Takeda therapy gets speedy FDA nod for lung cancers with rare genetic signature

Takeda Pharmaceutical drug mobocertinib was approved by the FDA to treat non-small cell lung cancer in patients whose tumors carry a rare genetic signature. With the approval, Takeda can offer an oral alternative to a recently approved Johnson & Johnson drug that targets the same mutation but is given as an infusion.

Customizable CDMO Solutions

Emergent BioSolutions provides end-to-end service for all your drug substance and product development and manufacturing needs.

Aspiro Pharma -Walk-In Interviews for Production/Warehouse Department On 19th September 2021

Aspiro Pharma -Walk-In Interviews for Production/Warehouse Department On 19th September 2021 Job Description Greetings from Aspiro Pharma (Hetero Group) !! Walk-In Interviews for Production Department: Production Position: Officer-Sr. Executive Experience: 1 -7 years Qualification: M.Sc / B.Pharma / M.Pharma Department: Warehouse Position: Officer-Sr. Executive Experience: 1 -6 years Qualification: M.Sc / B.Sc / M.BA Time and Venue Details: :  Walk-In Interview On 19th September …

Aspiro Pharma -Walk-In Interviews for Production/Warehouse Department On 19th September 2021 Read More »

5 Things to Know About DDoS Attacks in Healthcare

Distributed denial of service attacks are commonly used to target financial institutions, government infrastructure and cloud service providers. In 2020, however, DDoS attacks took on greater significance for healthcare providers as more hospitals than ever were targeted. Cybercriminals use denial of service attacks to overwhelm networks and applications and take them offline. Distributed denial of …

5 Things to Know About DDoS Attacks in Healthcare Read More »

‘Everybody Is Facing This Problem’: Staffing Struggles Force In-Home Care Providers to Turn Away Business

Sign up for HHCN + to read this exclusive content. Individual Membership $400 per year Purchase Group 2–5 members$380 per year* Purchase Need more than 5 members? Contact us for more information. * per member Already a member? Login The post ‘Everybody Is Facing This Problem’: Staffing Struggles Force In-Home Care Providers to Turn Away …

‘Everybody Is Facing This Problem’: Staffing Struggles Force In-Home Care Providers to Turn Away Business Read More »

Neuland Laboratories Pvt. Ltd-Walk-In Interviews for Production/ Quality Control On 17th to 25th Sept’ 2021

Neuland Laboratories Pvt. Ltd-Walk-In Interviews for Production/ Quality Control On 17th to 25th Sept’ 2021 Job Description Neuland Laboratories Limited, We are hiring for Production Chemist candidates having experience of minimum 3 years in API Industry for Neuland Unit-3, Kazipally location. Walk-Ins API Production Shift-Chemist at Neuland Laboratories Limited Department : Production Designation: Shift Chemist Experience: 3 to …

Neuland Laboratories Pvt. Ltd-Walk-In Interviews for Production/ Quality Control On 17th to 25th Sept’ 2021 Read More »

How pharmacists can partner with health coaches

What is a health coach? A health coach is someone with expertise in wellness who assists people achieve good health by being a mentor and educator on lifestyle and nutritional changes. It is important to understand that health coaching is not only about nutrition, but instead, health coaches offer people a holistic approach to creating …

How pharmacists can partner with health coaches Read More »

Vectura investors ignore critics and back tobacco giant takeover

Tobacco giant Philip Morris International (PMI) has won the shareholder vote it needed for its controversial £1.1 billion takeover of respiratory drugmaker Vectura, despite mobilised opposition to the deal. PMI said it had won support from enough shareholders that – when added to its own holding in Vectura – it had a 75% position in …

Vectura investors ignore critics and back tobacco giant takeover Read More »

Research reveals drug targets for memory enhancement

New research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders.

Idaho to ration care amid COVID-19 surge

Idaho on Thursday announced that it is activating a system for rationing medical care statewide amid a surge in COVID-19 cases that is overwhelming hospitals.The system known as Crisis Standards of Care allows hospitals to prioritize for care…

Racial Disparities in COVID-19 Impacts and Vaccinations for Children

COVID-19 has disproportionately negatively affected the physical and mental health, academic growth, and economic security of children of color. At the same time, the limited data available to date suggest some children of color may be less likely to receive a COVID-19 vaccine, leaving them at elevated risk as the virus continues to spread and …

Racial Disparities in COVID-19 Impacts and Vaccinations for Children Read More »

A Man With Sudden Onset of Gastroparesis

By HANS DUVEFELT Leo Dufour is not a diabetic. He is in his mid 50s, a light smoker with hypertension and a known hiatal hernia. He has had occasional heartburn and has taken famotidine for a few years along with his blood pressure and cholesterol pills. Over the past few months, he started to experience …

A Man With Sudden Onset of Gastroparesis Read More »

Sterilization Techniques for Parenteral Packaging

Thursday, September 16, 2021 at 10am EDT| 7am PDT| 3pm BST| 4pm CEST Choosing the right sterilization technique for your drug product and its packaging is not always a simple decision. Join the webcast on September 15th to learn about standard sterilization processes, be introduced to newer techniques, and understand how these techniques have been …

Sterilization Techniques for Parenteral Packaging Read More »

A defining characteristic of successful patient support programs is the level of cross-functional collaboration

There is a distinct difference between outstanding patient support programs and less effective programs. A defining characteristic of successful programs is the level of cross-functional collaboration. By following the six strategies in this white paper, pharmaceutical companies can improve collaboration, enhance the patient experience, better protect patient data, reduce risk, improve compliance—and improve the overall …

A defining characteristic of successful patient support programs is the level of cross-functional collaboration Read More »

CDC hindered pandemic response, Gottlieb says

Former FDA Commissioner Scott Gottlieb said in his new book “Uncontrolled Spread” that the Centers for Disease Control and Prevention hindered the coronavirus pandemic response, according to Axios. The book, scheduled for release on…

Sri Krishna Pharmaceuticals Ltd.-Walk-In Interviews for QC/ QA/ IPQA/ AQA/ Microbiology-API On 18th Sept’ 2021

Sri Krishna Pharmaceuticals Ltd.-Walk-In Interviews for QC/ QA/ IPQA/ AQA/ Microbiology-API On 18th Sept’ 2021 Job Description Company Profile:  Sri Krishna Pharmaceuticals Ltd (SKPL), established in 1974, started life as a pioneer in the bulk manufacturing of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple …

Sri Krishna Pharmaceuticals Ltd.-Walk-In Interviews for QC/ QA/ IPQA/ AQA/ Microbiology-API On 18th Sept’ 2021 Read More »

Insights+: The US FDA New Drug Approvals in August 2021

The US FDA has approved 3 BLAs and 2 NDAs in 2021, leading to treatments for patients and advances in the health care industry The Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have approved 48 novel products in 2021 Additionally, last year in 2020, the US FDA …

Insights+: The US FDA New Drug Approvals in August 2021 Read More »

Virus surge twice as bad in Reno as Vegas; hospitals filling

The 30-day average number of daily new cases per 100,000 residents has increased five-fold in the Reno-Sparks area over the past six weeks, from 354 at the beginning of August to 1,621 now, Washoe County Health District Officer Kevin Dick said.

How to use OiRA tools to prevent musculoskeletal disorders

16/09/2021 How to use OiRA tools to prevent musculoskeletal disorders Risk assessment is an essential first step in the prevention of occupational accidents and work-related health problems. To make this process easier, EU-OSHA developed OiRA — an Online Interactive Risk Assessment, which has been already in use since…

Series of FDA’s Approvals in ALS Drdeservesymphoma Space; Roche, Temedica Forges Digital Companionship, Shares of Sage Therapeutics Rises

FDA’s Go-Ahead to Amylyx New Drug Application for ALS Drug  Amylyx Pharmaceuticals has announced its plan to submit a New Drug Application (NDA) to the U.S. FDA for its drug, AMX0035 (sodium phenylbutyrate (PB) and Taurursodiol (TURSO)), for the treatment of Amyotrophic lateral sclerosis (ALS).  A few months ago, the company had decided to file …

Series of FDA’s Approvals in ALS Drdeservesymphoma Space; Roche, Temedica Forges Digital Companionship, Shares of Sage Therapeutics Rises Read More »

BMS Reports Five-Year Data of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate -214 for the Treatment of Advanced or Metastatic Renal Cell Carcinoma

Shots: The P-III CheckMate -214 trial evaluates Opdivo (3mg/kg) + Yervoy (1mg/kg, q3w for 4 doses) vs sunitinib in 1096 patients with previously untreated advanced/mRCC Results: @median follow-up of 67.7mos., combination showed superior OS in intermediate, poor risk patients & randomized or ITT population; m-OS (47.0 vs 26.6mos.) & (55.7 vs 38.4mos.); ORR (42% vs …

BMS Reports Five-Year Data of Opdivo (nivolumab) + Yervoy (ipilimumab) in P-III CheckMate -214 for the Treatment of Advanced or Metastatic Renal Cell Carcinoma Read More »

Sanders ‘disappointed’ in House panel’s vote on drug prices

Sen. Bernie Sanders (I-Vt.) said he is “disappointed” with a House panel’s vote on Wednesday to block legislation to lower drug prices. “I’m very disappointed in the vote today on prescription drugs by the House Energy and…

Taking stock of NHS medicines optimisation

Given the rising cost of medicines as a share of the NHS budget in England, the establishment of ICSs provides a timely opportunity to take stock on delivering medicines optimisation at local level, says NHS Gloucestershire CCG’s Ellen Rule. Medicines optimisation aims to improve health outcomes, service quality, and sustainability by ensuring patients are taking …

Taking stock of NHS medicines optimisation Read More »

Lead Contamination in Calcium Supplements 

Do calcium citrate and calcium carbonate have as much lead as calcium supplements derived from dolomite and animal bone?  You may remember I’ve explored the role calcium supplements may play in reducing lead exposure during pregnancy and breastfeeding, but that assumes the supplements themselves are not contaminated. Supplements with lead?  It all started with an extraordinary case report published in 1977, entitled “Lead-Contaminated Health Food.” As I discuss in my video Lead in Calcium …

Lead Contamination in Calcium Supplements  Read More »

Amgen Presents Results of Lumakras (sotorasib) + Vectibix (panitumumab) in P-Ib/II CodeBreaK 101 study for KRAS G12C-Mutated Colorectal Cancer at ESMO21 2021

Shots: The P-Ib/II CodeBreaK 101 study evaluates Lumakras + Vectibix in 31 patients with KRAS G12C-mutated advanced CRC The results demonstrated ORR (27%) among 26 patients in the efficacy analysis, DCR (81%), 33% of patients experienced a response in the expansion cohort, no patients experienced dose-limiting toxicities during the 28 days following initial treatment. The …

Amgen Presents Results of Lumakras (sotorasib) + Vectibix (panitumumab) in P-Ib/II CodeBreaK 101 study for KRAS G12C-Mutated Colorectal Cancer at ESMO21 2021 Read More »

Sin papeles, sin atención: migrantes con discapacidades buscan ayuda a través de demandas y activismo

Hace 13 años, la desesperación llevó a José Luis Hernández a subirse a un tren que iba a alta velocidad en el norte de México con la esperanza de llegar a los Estados Unidos. Pero no lo logró. Resbaló y cayó bajo las ruedas de acero: perdió el brazo y la pierna derechas, y cuatro …

Sin papeles, sin atención: migrantes con discapacidades buscan ayuda a través de demandas y activismo Read More »

INVEST Digital Health Preview: How Has RPM Reimbursement Evolved and Where Does it Need to Go?

INVEST Digital Health is set for September 20-23. Held in a virtual format due to Covid-19, the healthcare conference brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval

Takeda has had a run of bad luck with its Wave1 pipeline of new drug candidates of late, but can now celebrate a vestry after getting FDA approval for first-in-class lung cancer therapy Exkivity. The US regulator has cleared the tyrosine kinase inhibitor (TKI) as a second-line treatment for locally advanced or metastatic non-small-cell lung …

Takeda gets a win for its Wave1 pipeline, as Exkivity nabs FDA approval Read More »

NICE backs BioCryst’s Orladeyo for hereditary angioedema

BioCryst Pharma’s Orladeyo has been recommended by NICE as a treatment for the rare disease hereditary angioedema (HAE) in England, Wales and Northern Ireland. Orladeyo (berotralstat) – which was approved by the EMA and MHRA in April and May, respectively – is set to become the first oral, once-daily therapy that can be used to …

NICE backs BioCryst’s Orladeyo for hereditary angioedema Read More »

BioCryst’s Orladeyo (berotralstat) Receives NICE Recommendation as First Oral Therapy to Prevent HAE Attacks in the UK

Shots: The NICE recommendation is based on P-III APeX-2 trial evaluating Orladeyo vs PBO in adult & pediatric patients aged ≥12yrs. with HAE attacks The trial met its 1EPs i.e., reduction in HAE attacks @24wks. & sustained through 96wks. with an 80% reduction in patients with mean HAE attack rate/mos. @ 25-96wks. The therapy was …

BioCryst’s Orladeyo (berotralstat) Receives NICE Recommendation as First Oral Therapy to Prevent HAE Attacks in the UK Read More »

SMS Lifesciences -Walk-In Interview for Freshers & Experienced in Production On 17th & 18th September 2021

SMS Lifesciences -Walk-In Interview for Freshers & Experienced in Production On 17th & 18th September 2021 Job Description Company Profile:  SMS Lifesciences India Limited is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, …

SMS Lifesciences -Walk-In Interview for Freshers & Experienced in Production On 17th & 18th September 2021 Read More »

Pandemic frustrations zero in on unvaccinated Americans

The growing frustration with the ongoing pandemic is boiling over, with all eyes turned to the unvaccinated as the key to getting through the COVID-19 crisis.As cases approach winter levels, the U.S. has been left to decide how to deal with and…

Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dips

Pfizer and Moderna have both reported data that they say backs up the need for booster shots of their COVID-19 vaccines ahead of an FDA advisory committee meeting tomorrow, although the regulator seems less convinced. Documents published ahead of the panel by the FDA reviewers suggest that there is some evidence from observational studies that …

Ahead of FDA adcomm, Pfizer, Moderna say COVID jab efficacy dips Read More »

No Papers, No Care: Disabled Migrants Seek Help Through Lawsuit, Activism

Desperation led José Luis Hernández to ride atop a speeding train through northern Mexico with hopes of reaching the United States 13 years ago. But he didn’t make it. Slipping off a step above a train coupling, he slid under the steel wheels. In the aftermath, he lost his right arm and leg, and all …

No Papers, No Care: Disabled Migrants Seek Help Through Lawsuit, Activism Read More »

How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters

In January — long before the first jabs of covid-19 vaccine were even available to most Americans — scientists working under Dr. Anthony Fauci at the National Institute of Allergy and Infectious Diseases were already thinking about potential booster shots. A month later, they organized an international group of epidemiologists, virologists and biostatisticians to track …

How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters Read More »

When Covid Deaths Are Dismissed or Stigmatized, Grief Is Mixed With Shame and Anger

[Editor’s note: This story contains language references that some readers may find offensive.] Months after Kyle Dixon died, his old house in Lanse, Pennsylvania, is full of reminders of a life cut short. His tent and hiking boots sit on the porch where he last put them. The grass he used to mow has grown …

When Covid Deaths Are Dismissed or Stigmatized, Grief Is Mixed With Shame and Anger Read More »

Merck Enters into a Clinical Collaboration with Hookipa to Evaluate Keytruda (pembrolizumab) + HB-200 as 1L Treatment of Advanced Head and Neck Cancers

Shots: The companies collaborated to evaluate Hookipa’s HB-200 (arenaviral immunotherapeutic) + Merck’s Keytruda (anti-PD-1 therapy) in a P-II trial for patients with advanced HNSCC, based on an ongoing P-I/II trial of HB-200 for advanced HPV16+ cancers patients HB-201 monothx. showed an ORR (18%), m-PFS (3.45mos.) in heavily pretreated head & neck cancer patients. Preliminary data …

Merck Enters into a Clinical Collaboration with Hookipa to Evaluate Keytruda (pembrolizumab) + HB-200 as 1L Treatment of Advanced Head and Neck Cancers Read More »

Amylyx preps filing for its ALS drug after FDA feedback

Just a few months ago, Amylyx was talking about having to complete another clinical trial before it could file for FDA approval of its drug for neurodegenerative disease amyotrophic lateral sclerosis (ALS). It’s now accelerating those plans, citing favourable discussions with the US regulator. The company revealed today that it will submit its marketing application …

Amylyx preps filing for its ALS drug after FDA feedback Read More »

Biogen to Initiate P-IIIb ASCEND Study Evaluating Higher Doses of Spinraza (nusinersen) for the Treatment of Spinal Muscular Atrophy

Shots: The P-IIIb ASCEND study will evaluate the clinical outcomes & safety of the higher doses of nusinersen in 135 patients aged 5-39yrs. with SMA prior treated with Evrysdi at MRD (5mg). Patients will receive 2 loading doses of nusinersen (50mg, 2wks. apart), followed by a maintenance dose of 28mg, q4mos. in study period & …

Biogen to Initiate P-IIIb ASCEND Study Evaluating Higher Doses of Spinraza (nusinersen) for the Treatment of Spinal Muscular Atrophy Read More »

Zydus Cadila – Walk-In Interviews for QA/ QC/ Production/ Packing On 19th Sept’ 2021

Zydus Cadila – Walk-In Interviews for QA/QC/ Production/ Packing On 19th Sept’ 2021 Job Description Zydus Cadila – Walk-In Interviews @ Indore We are recruiting for our Greenfield, Formulation Manufacturing Plant Located at Ahmedabad. •Asst. Manager/Dy. Manager – Quality Assurance (IPQA / Qualification/QMS)  B. Pharm / M.Sc. / M. Pharm with 7 to 10 Years …

Zydus Cadila – Walk-In Interviews for QA/ QC/ Production/ Packing On 19th Sept’ 2021 Read More »

Takeda’s Exkivity (mobocertinib) Receives the US FDA’s Approval as the First Oral Therapy for EGFR Exon20 Insertion+ NSCLC

Shots: The approval is based on the P-I/II trial evaluating Exkivity (160 mg) in 114 patients with EGFR Exon20 insertion+ NSCLC who received prior Pt-based therapy The results demonstrated ORR (28%) as assessed by IRC & 35% as per investigator, m-DoR (17.5mos.), m-OS (24mos.), and m-PFS (7.3mos.) as per IRC Exkivity is a TKI inhibitor …

Takeda’s Exkivity (mobocertinib) Receives the US FDA’s Approval as the First Oral Therapy for EGFR Exon20 Insertion+ NSCLC Read More »

Assessing the Opportunities and Challenges in the Oncology Segment

Oncology is the study of cancer and encompasses the diagnosis and treatment of cancer. The treatment of cancer requires a multidisciplinary approach which includes medications, surgical, and radiation. The type of approach adopted depends upon the stages, age, and the patient’s preference. Cancer encompasses a group of diseases, which can affect any organ or tissue …

Assessing the Opportunities and Challenges in the Oncology Segment Read More »

Evaluating the Present and Future Oncology Market Outlook With Valued Research and Analysis

Oncology deals with the diagnosis and treatment of cancer. It is one of the most dynamic segments moving at a rapid pace in terms of research and development activities, diagnostics, and treatment. Oncology encompassed several diseases (or indications). Oncology Based Indications are further classified as Blood cancer, Solid tumors, and Lymphomas.  Over the past few …

Evaluating the Present and Future Oncology Market Outlook With Valued Research and Analysis Read More »

Top 12 Oncologists in India | Best Cancer Doctors in India

Who is a Cancer Specialist? Cancer is an illness that leads to the uncontrollable division of cells going into neighboring tissues. Malignant growths or cancerous growths can develop in various body parts. Cancer involves disabling our bodys’ control mechanisms to a certain extent. A doctor who provides treatment for cancer and concerning medical care is …

Top 12 Oncologists in India | Best Cancer Doctors in India Read More »

ToolGen Files Opposition to Broad Contingent Preliminary Motion No. 2 to Add Claims Corresponding to the Count

By Kevin E. Noonan — On May 28th, Junior Party the Broad Institute, Harvard University and MIT (collectively, “Broad”) filed its Contingent Preliminary Motion No. 2 in CRISPR Interference No. 106,126 (where ToolGen is the Senior Party), pursuant to 37 C.F.R. §§ 41.121(a)(1)(i) and 41.208(a)(2) and Standing Order (“SO”) 203.2. This motion is contingent on …

ToolGen Files Opposition to Broad Contingent Preliminary Motion No. 2 to Add Claims Corresponding to the Count Read More »

Complexities of COVID-19 manufacturing

Getting from a mRNA COVID-19 vaccine to scaling to manufacture these vaccines for billions of people is far from simple: Manufacturing mRNA vaccines for the first time in a very short timeframe required significant innovation and remains a technically challenging endeavor. The process proved to be technically challenging as Pfizer developed a 50,000 step process. …

Complexities of COVID-19 manufacturing Read More »

Reimagining Patient Support Through Digital Peer Coaching Programs

Dr. Rosemary Ku VP of Medical Affairs at Better Health Studies have found that social connectedness is so critical to human life that loneliness is more dangerous than obesity and isolation can increase mortality by 30%. Peer support, which is a system of giving and receiving help from others with a shared experience, not only …

Reimagining Patient Support Through Digital Peer Coaching Programs Read More »

Shilpa Medicare Limited-Walk-In Interviews for Analytical Services On 18th Sept’ 2021

Shilpa Medicare Limited-Walk-In Interviews for Analytical Services On 18th Sept’ 2021 Job Description Walk-In Interviews @ Shilpa Medicare Limited Executive / Senior Executive-Analytical Services Experience: 02-06 years Openings: 05 Job Location: Nacharam, Hyderabad JD: The candidate should have the knowledge and experience in on Analytical method validation, method transfer and method equivalency analysis as per ICH guidelines. …

Shilpa Medicare Limited-Walk-In Interviews for Analytical Services On 18th Sept’ 2021 Read More »

Torrent Pharmaceuticals- Walk-In Interviews for Regulatory Affairs On 19th September 2021

Torrent Pharmaceuticals- Walk-In Interviews for Regulatory Affairs On 19th September 2021 Job Description Department: Regulatory Affairs Experience: 02-15 years Position: Executive /  Assistant Manager/ Manager Qualification: : M.Sc/ M.Pharma Interested Candidates may share their CVs on vilshashah@torrentpharma.com / anupathale@torrentpharma.com Date: 19th September 2021 Time: 10:00 AM to 5:00 PM Venue: Hotel Four Points By Sheraton, Vadodara. 1275 ward No. 7, Fatehganj, Vadodara, Gujarat Contact: Anup …

Torrent Pharmaceuticals- Walk-In Interviews for Regulatory Affairs On 19th September 2021 Read More »

Vital Pharma -Walk-In Interviews for Marketing On Sept’ 2021 @ Hyderabad

Vital Pharma -Walk-In Interviews for Marketing On Sept’ 2021 @ Hyderabad Job Description Walk-In Interviews for Business Development (BD)-Executive, Business Development & Marketing (BDM) @ Vital Pharma Department: Marketing Position: Business Development (BD)-Executive Qualification: MBA/PGDM Experience: 4-8 years in Pharma Experience in B to B Department: Marketing Position: Business Development & Marketing (BDM) Qualification: MBA/PGDM Experience: 10-15 years in Pharma Experience in B to B Email:  hr@vitalpharma.in …

Vital Pharma -Walk-In Interviews for Marketing On Sept’ 2021 @ Hyderabad Read More »

Dice’s IPO roll comes up with $204M for R&D of oral drugs to rival biologics

Dice Therapeutics raised $204 million from its IPO to support development of oral drugs that could compete against biologic drugs that are injected or infused. Also debuting on the public markets were Tyra Biosciences and Procept BioRobotics.

Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Bill

Senior Democrats said they could still preserve elements of their plan to lower prescription drug prices, but they have little room for defections, and divisions remain on that and other issues.

Overnight Health Care — Democrats face setback on drug pricing

Welcome to Wednesday’s Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. Subscribe here: thehill.com/newsletter-signup.It’s been over a week, and the zebras running loose in Maryland—which were…

FDA strikes cautious tone ahead of vaccine booster meeting

Influential government advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective — the first step toward deciding which Americans need one and when.

House panel rejects drug pricing plan in setback to Biden

A House committee dealt an ominous setback Wednesday to President Joe Biden’s social and environment package, derailing a money-saving plan to let Medicare negotiate the price it pays for prescription drugs.

Largest US colleges push for students to get vaccinated

As the new school year begins, some of the country’s largest colleges are taking various approaches to enforcing vaccine mandates or encouraging students to get vaccinated on their own. According to a report from The Associated Press, 26 of the…

First Lady visits schools to discuss COVID-19

First Lady Jill Biden visited schools in Des Moines, Iowa, and Milwaukee, Wisconsin, on Wednesday to discuss in-person learning and COVID-19.She first visited Marvin Pratt Elementary School in Milwaukee in the early afternoon, touting the…

Lawsuit: Aetna fertility coverage policy “an illegal tax” on LGBTQ people

The lawsuit alleges that an Aetna policy discriminates against LGBTQ people by requiring them to pay thousands in out-of-pocket costs for fertility treatments before becoming eligible for coverage. Though Aetna has agreed to pay the costs incurred by the plaintiffs, the suit aims to strike down the policy as a whole.

CVS Caremark Expands Efforts to Tackle Health Disparities

What You Should Know:  – CVS Caremark announced an expansion of its efforts to address health disparities among patients, starting with certain conditions including sickle cell disease, HIV, and cardiovascular disease. – CVS Caremark is working with its clients to create health equity strategies for PBM members with certain conditions that disproportionately affect patients of …

CVS Caremark Expands Efforts to Tackle Health Disparities Read More »

Study of Covid Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

Swift Medical Launches AI Digital Wound App to Support Clinical Trials

What You Should Know: Global digital wound care provider Swift Medical, today announced the launch of a new application specifically designed to help pharma and med device researchers conduct decentralized clinical trials. Since patients are now doing more trials at home, study coordinators have had trouble tracking skin side effects remotely — or trusting patients …

Swift Medical Launches AI Digital Wound App to Support Clinical Trials Read More »

Edifecs Acquires Talix to Expand Risk Adjustment Solution

What You Should Know: – Edifecs, a global health IT provider announced it is acquiring Talix, a SaaS IT company, to expand Edifecs’ reach in the encounter management and risk adjustment space. Financial details of the acquisition were not disclosed. – The integration of Edifecs’ and Talix’s technologies will create an expanded risk adjustment solution …

Edifecs Acquires Talix to Expand Risk Adjustment Solution Read More »

Study of Booster Shot Benefits Fans Debate Over Extra Doses

Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.

North Dakota hospital executive: ‘We are in a crisis’

A top official at North Dakota’s largest health system said his hospitals don’t have the staff to deal with the surging number of COVID-19 cases.“We really are in crisis,” Doug Griffin, vice president and medical officer of Sanford Health in Fargo…

Future Leader: Nick Muscato, Amedisys Senior Vice President of Finance

The Future Leaders Awards program is brought to you in partnership with PointClickCare. The program is designed to recognize up-and-coming industry members who are shaping the next decade of senior housing, skilled nursing, home health and hospice care. To see this year’s future leaders, visit https://futureleaders.agingmedia.com/. Nick Muscato, senior vice president of finance at Baton …

Future Leader: Nick Muscato, Amedisys Senior Vice President of Finance Read More »

Relative importance of pharmaceuticals on health outcomes: 1990-2015

Health outcomes have improved in the US over the last 25 years. Clearly public health initiatives (e.g., reduced smoking rates) is having an impact, but another key key question is, what is medical technologies are driving these gains? Is it new surgical techniques, better diagnostics, improved medical devices, or new pharmaceuticals? This answer is difficult …

Relative importance of pharmaceuticals on health outcomes: 1990-2015 Read More »

4 best practices to prevent rapid disenrollment for Medicare Advantage plans

With the 2022 Annual Election Period (AEP) for Medicare Advantage (MA) plans beginning next month, MA plans are in the final stages of preparing to enroll new members as well as retain returning members to the plan. Soon, the Annual Notice of Change (ANOC) will be in members’ mailboxes, informing them of changes in cost, …

4 best practices to prevent rapid disenrollment for Medicare Advantage plans Read More »

Democrats suffer blow on drug pricing as 3 moderates buck party

Democrats’ signature legislation to lower drug prices was defeated in a House committee on Wednesday as three moderate Democrats voted against their party.Reps. Kurt Schrader (D-Ore.), Scott Peters (D-Calif.), and Kathleen Rice (D-N.Y.) voted…

24 Hour Home Care Buys Non-Medical Division of Home Health ‘Bundling Expert’ GrandCare

Often in the home-based care field, transactions are driven by companies seeking to expand their service lines to become one-stop shops for referral partners. Sometimes, however, dealmaking is ignited by a desire to double down on existing expertise. An example of the latter M&A tactic happened Wednesday, with 24 Hour Home Care buying the non-medical …

24 Hour Home Care Buys Non-Medical Division of Home Health ‘Bundling Expert’ GrandCare Read More »

Home Health Providers Seek Clarity on CMS Plan to Resume TPE Program

As a response to the COVID-19 emergency, the U.S. Centers for Medicare & Medicaid Services (CMS) pressed pause on the targeted probe and educate (TPE) program in March 2020. A year later, CMS has plans to resume the program, according to an August 2021 MLNConnects newsletter. Broadly, TPE is a medical review program that began …

Home Health Providers Seek Clarity on CMS Plan to Resume TPE Program Read More »

Trinidad health minister shoots down Minaj claims about vaccines

The Health Minister of Trinidad and Tobago shot down claims made by rapper Nicki Minaj this week that a friend of her cousin in the country had experience adverse side effects after receiving a coronavirus vaccine. “One of the reasons we…

24 Democratic AGs back Biden bid to block Texas abortion law

Two dozen Democratic attorneys general on Wednesday threw their weight behind the Biden administration’s effort to block Texas’s new abortion law.In an amicus brief, the group argued that Texas’s restrictive measure lies in “direct contravention” of…

Vasant Chemicals Pvt. Ltd-Walk-In Interviews for Production/ QC/ QA On 19th Sept’ 2021

Vasant Chemicals Pvt. Ltd-Walk-In Interviews for Production/ QC/ QA On 19th Sept’ 2021 Job Description Department: Production/ QC/QA Qualification: B.Sc/ M.Sc/ B.Tech/ Diploma Experience: 1-10 years Location: ATCHUTAPURAM, Vizag Date: 19th September 2021 Timings: 8:30 AM to 11:30 AM Venue: Vasant Chemicals Pvt. Ltd, Plot No: 10 A, Western Sector, APSEZ- ATCHUTAPURAM, Visakhapatnam-Dist, A.P Vasant Chemicals Pvt. Ltd-Walk-In Interviews for Production/ QC/ QA …

Vasant Chemicals Pvt. Ltd-Walk-In Interviews for Production/ QC/ QA On 19th Sept’ 2021 Read More »

Analysis: Cost of care for unvaccinated Covid patients spikes to $5.7B

The cost of hospital care for unvaccinated Covid-19 patients has more than doubled, jumping from about $2 billion to $5.7 billion over the summer. And this figure may still be lower than the actual cost burden unvaccinated people represent to the healthcare system.

Aurobindo Pharma Ltd- Hiring freshers for Formulation Analytical Department- Apply Now

Aurobindo Pharma Ltd- Hiring freshers for Formulation Analytical Department- Apply Now Company Profile: Aurobindo Pharma Ltd’ (APL).  APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. Job Description Greetings from Aurobindo …

Aurobindo Pharma Ltd- Hiring freshers for Formulation Analytical Department- Apply Now Read More »